Inhibition of β‐catenin/Tcf signaling by flavonoids
暂无分享,去创建一个
[1] Ying Su,et al. Soy isoflavone genistein upregulates epithelial adhesion molecule E-cadherin expression and attenuates beta-catenin signaling in mammary epithelial cells. , 2008, Carcinogenesis.
[2] C. Janson,et al. Systemic and local eosinophil inflammation during the birch pollen season in allergic patients with predominant rhinitis or asthma , 2007, Clinical and molecular allergy : CMA.
[3] Joshua D Deschamps,et al. Baicalein is a potent in vitro inhibitor against both reticulocyte 15-human and platelet 12-human lipoxygenases. , 2006, Bioorganic & medicinal chemistry.
[4] Chul-hak Yang,et al. Negative regulation of beta-catenin/Tcf signaling by naringenin in AGS gastric cancer cell. , 2005, Biochemical and biophysical research communications.
[5] Chul-hak Yang,et al. The inhibitory mechanism of curcumin and its derivative against β‐catenin/Tcf signaling , 2005, FEBS letters.
[6] Chul-hak Yang,et al. Quercetin, a potent inhibitor against beta-catenin/Tcf signaling in SW480 colon cancer cells. , 2005, Biochemical and biophysical research communications.
[7] M. Clapper,et al. beta-catenin-mediated signaling: a molecular target for early chemopreventive intervention. , 2004, Mutation research.
[8] K. Kashfi,et al. Nitric oxide-donating aspirin inhibits β-catenin/T cell factor (TCF) signaling in SW480 colon cancer cells by disrupting the nuclear β-catenin–TCF association , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[9] Yuguo Du,et al. Synthesis of biantennary β-D-(1→6) glucosamine oligosaccharides , 2003 .
[10] J. Szatkowski,et al. Tyrosine kinase inhibitor STI-571/Gleevec down-regulates the beta-catenin signaling activity. , 2003, Cancer letters.
[11] C. Blum,et al. Suppression of tumorigenesis in the Apc(min) mouse: down-regulation of beta-catenin signaling by a combination of tea plus sulindac. , 2003, Carcinogenesis.
[12] A. Jaiswal,et al. β-Catenin-mediated transactivation and cell–cell adhesion pathways are important in curcumin (diferuylmethane)-induced growth arrest and apoptosis in colon cancer cells , 2002, Oncogene.
[13] R. Dashwood,et al. Inhibition of beta-catenin/Tcf activity by white tea, green tea, and epigallocatechin-3-gallate (EGCG): minor contribution of H(2)O(2) at physiologically relevant EGCG concentrations. , 2002, Biochemical and biophysical research communications.
[14] C. Fenoglio-Preiser,et al. beta-Catenin mutation is a frequent cause of Wnt pathway activation in gastric cancer. , 2002, Cancer research.
[15] M. Makuuchi,et al. Frequent β-catenin aberration in human hepatocellular carcinoma , 2001 .
[16] H. Lee,et al. Altered expression and mutation of β‐catenin gene in gastric carcinomas and cell lines , 2001 .
[17] A. Siermann,et al. The nonsteroidal anti-inflammatory drugs aspirin and indomethacin attenuate β-catenin/TCF-4 signaling , 2001, Oncogene.
[18] H. Daniel,et al. Comparative analysis of the effects of flavonoids on proliferation, cytotoxicity, and apoptosis in human colon cancer cell lines , 1999, European journal of nutrition.
[19] Frank McCormick,et al. β-Catenin regulates expression of cyclin D1 in colon carcinoma cells , 1999, Nature.
[20] W F Bodmer,et al. Target genes of beta-catenin-T cell-factor/lymphoid-enhancer-factor signaling in human colorectal carcinomas. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[21] A. Sparks,et al. Identification of c-MYC as a target of the APC pathway. , 1998, Science.
[22] H. Boeing,et al. Falvonole, Flavone und Anthocyane als natürliche Antioxidantien der Nahrung und ihre mögliche Rolle bei der Prävention chronischer Erkrankungen , 1998 .
[23] G. Williamson,et al. Glucosinolates and phenolics as antioxidants from plant foods. , 1998, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.
[24] A. Levine,et al. The role of beta‐catenin in cell adhesion, signal transduction, and cancer , 1998, Current opinion in oncology.
[25] M. Mareel,et al. E‐cadherin/catenin/cytoskeleton complex: A regulator of cancer invasion , 1997, Journal of cellular physiology.
[26] Jörg Stappert,et al. β‐catenin is a target for the ubiquitin–proteasome pathway , 1997 .
[27] Hans Clevers,et al. Activation of β-Catenin-Tcf Signaling in Colon Cancer by Mutations in β-Catenin or APC , 1997, Science.
[28] K. Kinzler,et al. Constitutive Transcriptional Activation by a β-Catenin-Tcf Complex in APC−/− Colon Carcinoma , 1997, Science.
[29] M. Fritsche,et al. Flavonoids activate wild-type p53. , 1996, Oncogene.
[30] Paul Polakis,et al. Binding of GSK3β to the APC-β-Catenin Complex and Regulation of Complex Assembly , 1996, Science.
[31] Y. Nakamura,et al. Somatic mutation of the APC gene in gastric cancer: frequent mutations in very well differentiated adenocarcinoma and signet-ring cell carcinoma. , 1992, Human molecular genetics.
[32] Bert Vogelstein,et al. APC mutations occur early during colorectal tumorigenesis , 1992, Nature.
[33] Yuguo Du,et al. Synthesis of biantennary beta-D-(1-->6) glucosamine oligosaccharides. , 2003, Carbohydrate research.
[34] M. Gerritsen,et al. Flavonoids: inhibitors of cytokine induced gene expression. , 1998, Advances in experimental medicine and biology.
[35] S. Kuo,et al. Dietary flavonoid and cancer prevention: evidence and potential mechanism. , 1997, Critical reviews in oncogenesis.